News | January 06, 2026
PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
India’s pharmaceutical sector stands at a pivotal inflection point
India’s pharmaceutical sector stands at a pivotal inflection point
Pembrolizumab has shown meaningful benefit only when combined with chemotherapy
The decision positions Yartemlea as the first and only approved inhibitor of the lectin pathway of complement
The company said it received notice on January 1 from the FDA’s Center for Veterinary Medicine that the funding will support its ongoing effectiveness study of Canalevia-CA1
The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
Once finalized, cough syrups will no longer be available for over-the-counter sale
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
Motiva, SmoothSilk, Round and Ergonomix implants represent the latest in plastic surgery innovation
The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
The SAPIEN M3 transcatheter mitral valve replacement (TMVR) system is designed for patients with symptomatic moderate-to-severe or severe MR
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
